Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis: The OLYMPIA 1 Randomized Clinical Phase 3 Trial.
Ständer S, Yosipovitch G, Legat FJ, Reich A, Paul C, Simon D, Naldi L, Metz M, Tsianakas A, Pink A, Fage S, Micali G, Weisshaar E, Sundaram H, Metelitsa A, Augustin M, Wollenberg A, Homey B, Fargnoli MC, Sofen H, Korman NJ, Skov L, Chen X, Jabbar-Lopez ZK, Piketty C, Kwatra SG; OLYMPIA 1 Investigators. Ständer S, et al. Among authors: legat fj. JAMA Dermatol. 2024 Nov 27. doi: 10.1001/jamadermatol.2024.4796. Online ahead of print. JAMA Dermatol. 2024. PMID: 39602139
Stigmatization and perceived health status in patients with hidradenitis suppurativa: an observational multicenter study in Europe.
Marron SE, Gracia-Cazaña T, Sampogna F, Schut C, Kupfer J, Dalgard FJ, Bewley A, van Beugen S, Gieler U, Lien L, Ständer S, Vulink N, Finlay AY, Legat FJ, Titeca G, Jemec GB, Misery L, Szabo C, Grivcheva-Panovska V, Spillekom-van Koulil S, Balieva F, Szepietowski JC, Reich A, Roque Ferreira B, Lvov A, Romanov D, Svensson A, Altunay IK, Thompson AR, Zeidler C, Tomas-Aragones L; ESDAP Study Collaborators. Marron SE, et al. Among authors: legat fj. Int J Dermatol. 2024 Nov 11. doi: 10.1111/ijd.17569. Online ahead of print. Int J Dermatol. 2024. PMID: 39526558
Happiness across the borders-A cross-sectional study among patients with psoriasis and atopic dermatitis in Europe.
Ziehfreund S, Wecker H, Mittag S, Weis J, Tizek L, Verkhoturova V, Legat FJ, Weger W, Großschädl K, Cerpes U, Sadoghi B, Riegler M, Balato A, Di Brizzi EV, Buononato D, Babino G, Calzavara-Pinton P, Rossi MT, Rovaris S, Dimech A, Boffa MJ, Chernyshov P, Svyatenko T, Kolodzinska L, Sikora M, Torres T, Manolache L, Scala E, Biedermann T, Zink A. Ziehfreund S, et al. Among authors: legat fj. J Eur Acad Dermatol Venereol. 2024 Aug 14. doi: 10.1111/jdv.20288. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 39140310
Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials.
Silverberg JI, Wollenberg A, Reich A, Thaçi D, Legat FJ, Papp KA, Stein Gold L, Bouaziz JD, Pink AE, Carrascosa JM, Rewerska B, Szepietowski JC, Krasowska D, Havlíčková B, Kalowska M, Magnolo N, Pauser S, Nami N, Sauder MB, Jain V, Padlewska K, Cheong SY, Fleuranceau Morel P, Ulianov L, Piketty C; ARCADIA 1 and ARCADIA 2 Study Investigators. Silverberg JI, et al. Among authors: legat fj. Lancet. 2024 Aug 3;404(10451):445-460. doi: 10.1016/S0140-6736(24)01203-0. Epub 2024 Jul 24. Lancet. 2024. PMID: 39067461 Clinical Trial.
A cross-sectional study on gender differences in body dysmorphic concerns in patients with skin conditions in relation to sociodemographic, clinical and psychological variables.
Sampogna F, Samela T, Abeni D, Schut C, Kupfer J, Bewley AP, Finlay AY, Gieler U, Thompson AR, Gracia-Cazaña T, Balieva F, Ferreira BR, Jemec GB, Lien L, Misery L, Marron SE, Ständer S, Zeidler C, Szabó C, Szepietowski JC, Reich A, Svensson A, Altunay IK, Legat FJ, Grivcheva-Panovska V, Romanov DV, Lvov AN, Titeca G, Vulink NC, Tomás-Aragones L, van Beugen S, Evers AWM, Dalgard FJ; European Society for Dermatology and Psychiatry (ESDaP) Study collaborators. Sampogna F, et al. Among authors: legat fj. J Eur Acad Dermatol Venereol. 2024 Jul 25. doi: 10.1111/jdv.20247. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 39051499
Stable Response and Sustained Improvement of Itch and Sleep Symptoms in Patients with Atopic Dermatitis Treated with Lebrikizumab over 52 Weeks.
Yosipovitch G, Lio P, Legat FJ, Chovatiya R, Deleuran M, Pierce E, Casillas M, Ding Y, Yang FE, Bardolet L, Ständer S. Yosipovitch G, et al. Among authors: legat fj. Dermatol Ther (Heidelb). 2024 Aug;14(8):2171-2180. doi: 10.1007/s13555-024-01225-w. Epub 2024 Jul 13. Dermatol Ther (Heidelb). 2024. PMID: 39002092 Free PMC article.
EADV Task Force Pruritus White Paper on chronic pruritus and chronic prurigo: Current challenges and future solutions.
Ständer S, Pereira MP, Zeidler C, Legat FJ, Misery L, Lönndahl L, Bewley AP, Brenaut E, Bobko S, Elberling J, Evers AWM, Garcovich S, Gieler U, Gonçalo M, Kupfer J, Lambert J, Lvov A, Metz M, Michenko A, Papadavid E, Reich A, Savk E, Schneider G, Schut C, Serra-Baldrich E, Ständer HF, Szepietowski JC, Wallengren J, Weisshaar E, Augustin M. Ständer S, et al. Among authors: legat fj. J Eur Acad Dermatol Venereol. 2024 Sep;38(9):1687-1693. doi: 10.1111/jdv.20102. Epub 2024 May 13. J Eur Acad Dermatol Venereol. 2024. PMID: 38738586
Chronic nodular prurigo: Association between comorbidities, itch and quality of life.
Pereira MP, Gutsche A, Weisshaar E, Halvorsen JA, Wallengren J, Legat FJ, Garcovich S, Savk E, Reich A, Bozek A, Lvov A, Bobko S, Metz M, Streit M, Misery L, Brenaut E, Serra-Baldrich E, Goncalo M, Szepietowski JC, Augustin M, Zeidler C, Ständer S. Pereira MP, et al. Among authors: legat fj. J Eur Acad Dermatol Venereol. 2024 Nov;38(11):e984-e988. doi: 10.1111/jdv.20038. Epub 2024 May 13. J Eur Acad Dermatol Venereol. 2024. PMID: 38736376 No abstract available.
Dermatological patients with itch report more stress, stigmatization experience, anxiety and depression compared to patients without itch: Results from a European multi-centre study.
Zeidler C, Kupfer J, Dalgard FJ, Bewley A, Evers AWM, Gieler U, Lien L, Sampogna F, Tomas Aragones L, Vulink N, Finlay AY, Legat FJ, Titeca G, Jemec GB, Misery L, Szabó C, Grivcheva Panovska V, Spillekom van Koulil S, Balieva F, Szepietowski JC, Reich A, Ferreira BR, Lvov A, Romanov D, Marron SE, Gracia Cazaña T, Elyas A, Altunay IK, Thompson AR, van Beugen S, Ständer S, Schut C. Zeidler C, et al. Among authors: legat fj. J Eur Acad Dermatol Venereol. 2024 Aug;38(8):1649-1661. doi: 10.1111/jdv.19913. Epub 2024 Mar 12. J Eur Acad Dermatol Venereol. 2024. PMID: 38468596
Lebrikizumab improved itch and reduced the extent of itch interference on sleep in patients with moderate-to-severe atopic dermatitis: two randomized, placebo-controlled, phase III trials.
Yosipovitch G, Lio PA, Rosmarin D, Serra-Baldrich E, Legat FJ, Casillas M, Pierce E, Liu Z, Sun L, Elmaraghy H, Ständer S. Yosipovitch G, et al. Among authors: legat fj. Br J Dermatol. 2024 Jan 23;190(2):289-291. doi: 10.1093/bjd/ljad435. Br J Dermatol. 2024. PMID: 37939793 Clinical Trial. No abstract available.
82 results